[HTML][HTML] Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran

L Zarei, N Moradi, F Peiravian… - International Journal for …, 2022 - Springer
Objectives This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method The “budget share” …

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran.

L Zarei, N Moradi, F Peiravian… - … Journal for Equity …, 2022 - search.ebscohost.com
Objectives: This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method: The" budget share" …

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran.

L Zarei, N Moradi, F Peiravian, N Hatami-Mazinani… - 2022 - cabidigitallibrary.org
Objectives: This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method: The" budget share" …

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran

L Zarei, N Moradi, F Peiravian… - … journal for equity …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method The" budget share" …

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran.

L Zarei, N Moradi, F Peiravian… - … Journal for Equity in …, 2022 - europepmc.org
Objectives This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method The" budget share" …

[HTML][HTML] Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran

L Zarei, N Moradi, F Peiravian… - … for Equity in …, 2022 - equityhealthj.biomedcentral.com
This study aimed to assess the financial burden of out-of-pocket (OOP) payments to
purchase antidiabetic medicines for type 2 patients in Iran. The “budget share” and “capacity …

[PDF][PDF] Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran

L Zarei, N Moradi, F Peiravian… - … Journal for Equity in …, 2022 - academia.edu
Objectives: This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method: The “budget share” …

[HTML][HTML] Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran

L Zarei, N Moradi, F Peiravian… - … Journal for Equity in …, 2022 - ncbi.nlm.nih.gov
Objectives This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method The “budget share” …

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran

L Zarei, N Moradi, F Peiravian… - … Journal for Equity in …, 2022 - pure.hud.ac.uk
Objectives This study aimed to assess the financial burden of out-of-pocket (OOP) payments
to purchase antidiabetic medicines for type 2 patients in Iran. Method The “budget share” …

[PDF][PDF] Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran

L Zarei, N Moradi, F Peiravian… - International Journal for …, 2022 - d-nb.info
Objectives: This study aimed to assess the financial burden of out‑of‑pocket (OOP) payments
to purchase antidia‑betic medicines for type 2 patients in Iran. Method: The “budget share” …